Lamivudine sulfoxide
- Level
- Commodity
- Parent
- 51343100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343118This classification denotes a reverse transcriptase inhibitor with the molecular formula C8H11N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L0EH965X85, chemically known as lamivudine sulfoxide, (3rs)-, but more generally known as lamivudine sulfoxide, which bears US NIH Compound Identifier 3081342. European Medicines Agency schedules lamivudine sulfoxide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08392MIG. Most nations, for tariff purposes, schedule lamivudine sulfoxide under HS 29349990. SMILES: C1CN(C(=O)NC1N)[C@@H]2C[S+]([C@@H](O2)CO)[O-].
Same parent
Under 51343100 · 17Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.